Human Placental Growth Hormone Variant in Pathological Pregnancies

Liao, Shutan, Vickers, Mark H., Stanley, Joanna L., Baker, Philip N. ORCID: https://orcid.org/0000-0002-4592-6427 and Perry, Jo K. (2018) Human Placental Growth Hormone Variant in Pathological Pregnancies. Endocrinology, 159 (5). pp. 2186-2198. ISSN 0013-7227

Full text not available from this repository. (Request a copy)

Abstract

Growth hormone (GH), an endocrine hormone, primarily secreted from the anterior pituitary, stimulates growth, cell reproduction, and regeneration and is a major regulator of postnatal growth. Humans have two GH genes that encode two versions of GH proteins: a pituitary version (GH-N/GH1) and a placental GH-variant (GH-V/GH2), which are expressed in the syncytiotrophoblast and extravillous trophoblast cells of the placenta. During pregnancy, GH-V replaces GH-N in the maternal circulation at mid-late gestation as the major circulating form of GH. This remarkable change in spatial and temporal GH secretion patterns is proposed to play a role in mediating maternal adaptations to pregnancy. GH-V is associated with fetal growth, and its circulating concentrations have been investigated across a range of pregnancy complications. However, progress in this area has been hindered by a lack of readily accessible and reliable assays for measurement of GH-V. This review will discuss the potential roles of GH-V in normal and pathological pregnancies and will touch on the assays used to quantify this hormone.

Item Type: Article
Uncontrolled Keywords: endocrinology ,/dk/atira/pure/subjectarea/asjc/1300/1310
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 22 Jan 2026 15:30
Last Modified: 18 Jun 2026 20:51
URI: https://ueaeprints.uea.ac.uk/id/eprint/101677
DOI: 10.1210/en.2018-00037

Actions (login required)

View Item View Item